From: Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
miRNA34a | miRNA192 | |||
---|---|---|---|---|
r | p-value | r | p-value | |
Age (yrs.) | 0.128 | 0.303 | 0.147 | 0.232 |
Gendera Male/female Percentage of male | 0.192 | 0.119 | 0.038 | 0.761 |
Hypertension No Yes | 0.255 | 0.037* | 0.075 | 0.541 |
Diabetes Absent Oral hypoglycemic On insulin | −0.005 | 0.967 | 0.000 | 1.000 |
BMI (kg/m2) | 0.140 | 0.267 | 0.087 | 0.487 |
Laboratory variables | ||||
Fasting blood glucose (mg/dl) | 0.366 | 0.016* | 0.177 | 0.251 |
HB (g/dL) | −0.456 | 0.022* | −0.194 | 0.342 |
Platelets (103/μL) | 0.043 | 0.839 | −0.193 | 0.344 |
Total leucocytic count (103/μL) | −0.417 | 0.038* | −0.335 | 0.095 |
AST (U/L) | −0.188 | 0.137 | −0.217 | 0.083 |
ALT (U/L) | −0.123 | 0.332 | −0.148 | 0.238 |
Total bilirubin (mg/dL) | 0.013 | 0.925 | 0.168 | 0.230 |
ALP (U/L) | −0.109 | 0.469 | 0.002 | 0.990 |
GGT (U/L) | −0.292 | 0.049* | −0.245 | 0.097 |
Total protein (g/dL) | −0.094 | 0.534 | −0.273 | 0.064 |
Serum albumin (g/dL) | −0.061 | 0.691 | −0.208 | 0.165 |
Cholesterol (mg/dl) | 0.233 | 0.068 | 0.077 | 0.550 |
Triglycerides (mg/dl) | 0.008 | 0.953 | 0.044 | 0.731 |
HDL (mg/dl) | 0.095 | 0.464 | −0.152 | 0.234 |
LDL (mg/dl) | −0.125 | 0.334 | −0.090 | 0.482 |
miRNA-192 | 0.584 | < 0.001** | 1 | - |